| File Note: |
The Board has issued CFE order dated 26.02.2020 to the industry for Pharmaceutical Formulation and for R&D purpose (for sustained release/extended release of drugs only and not for commercial purpose). Capacity not exceeding 1 Kg/day for all the products.
Now, the industry has applied for CFO fresh for the formulation of 7 products ie, Fluconazole Pellets, Terbinafine Hydrochloride Pellets, Escitalopram Oxalate Pellets, Dapoxetine Hydrochloride Pellets, S-Amlodipine Besylate, Luliconazole, Voriconazole, which were not mentioned in the CFE order. |
